The RISE Forum: A Research, Innovation, & Science Exchange: Clinical Trials in Interventional Oncology (Part 1)

Moderators: 

• Michael C. Soulen, MD, FSIR, FCIRSE
• Irene Bargellini, MD, Prof

Faculty: 

• Kristy Brock, PhD | From Bench to First-in-Human: Navigating the Regulatory Landscape
  • Learning Objectives:
    • Describe the basics of the current regulatory pathways for IR oncology devices and procedures

• Michael C. Soulen, MD, FSIR, FCIRSE | Endpoints That Matter: Selection of Clinically Meaningful Outcomes in IO Trials
  • Learning Objectives:
    • Describe trial design – with particular focus on the evolution of endpoints in cancer trials from response rates to patient-reported outcomes and survival metrics

• Nicholas J. Seewald, PhD | Statistical Considerations for IO-Specific Trial Designs
  • Learning Objectives:
    • Describe how to plan trials and what to consider regarding the specific trial design and for IR oncology studies

• Michael C. Soulen, MD, FSIR, FCIRSE; Irene Bargellini, MD, Prof; Richard S. Finn, MD | ROUNTABLE DISCUSSION: Addressing Challenges in IO Trial Design
  • Learning Objectives:
    • Interactive discussion on practical solutions to common methodological challenges